338 related articles for article (PubMed ID: 34342614)
1. FDA Regulation and Approval of Medical Devices: 1976-2020.
Darrow JJ; Avorn J; Kesselheim AS
JAMA; 2021 Aug; 326(5):420-432. PubMed ID: 34342614
[TBL] [Abstract][Full Text] [Related]
2. FDA Approval and Regulation of Pharmaceuticals, 1983-2018.
Darrow JJ; Avorn J; Kesselheim AS
JAMA; 2020 Jan; 323(2):164-176. PubMed ID: 31935033
[TBL] [Abstract][Full Text] [Related]
3. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
Ronquillo JG; Zuckerman DM
Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231
[TBL] [Abstract][Full Text] [Related]
4. Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process.
Heneghan CJ; Goldacre B; Onakpoya I; Aronson JK; Jefferson T; Pluddemann A; Mahtani KR
BMJ Open; 2017 Dec; 7(12):e017125. PubMed ID: 29212782
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
Rathi VK; Krumholz HM; Masoudi FA; Ross JS
JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
[TBL] [Abstract][Full Text] [Related]
6. The need for federal preemption of state tort claims in the context of "new drugs" and premarket-approved medical devices.
Mottes LM
Seton Hall Law Rev; 2011; 41(2):723-63. PubMed ID: 21739761
[No Abstract] [Full Text] [Related]
7. Oversight overhaul: eliminating the premarket review of medical devices and implementing a provider-centered postmarket surveillance strategy.
Scott B
Food Drug Law J; 2011; 66(3):377-404, ii. PubMed ID: 24505854
[TBL] [Abstract][Full Text] [Related]
8. New orthopedic devices and the FDA.
Sheth U; Nguyen NA; Gaines S; Bhandari M; Mehlman CT; Klein G
J Long Term Eff Med Implants; 2009; 19(3):173-84. PubMed ID: 20939777
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiology devices and the regulatory approval process within the U.S. FDA and abroad.
Selzman KA; Patel H; Cavanaugh K
J Interv Card Electrophysiol; 2019 Nov; 56(2):173-182. PubMed ID: 31418099
[TBL] [Abstract][Full Text] [Related]
10. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
Samuel AM; Rathi VK; Grauer JN; Ross JS
Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
[TBL] [Abstract][Full Text] [Related]
11. Renewing the Call for Reforms to Medical Device Safety-The Case of Penumbra.
Kadakia KT; Beckman AL; Ross JS; Krumholz HM
JAMA Intern Med; 2022 Jan; 182(1):59-65. PubMed ID: 34842892
[TBL] [Abstract][Full Text] [Related]
12. Medical devices: US medical device regulation.
Jarow JP; Baxley JH
Urol Oncol; 2015 Mar; 33(3):128-32. PubMed ID: 25458071
[TBL] [Abstract][Full Text] [Related]
13. Easing Medical Device Regulatory Oversight: The FDA and Testing Amidst the COVID-19 Pandemic.
Maxwell K
Am J Law Med; 2021 Jul; 47(2-3):291-326. PubMed ID: 34405782
[TBL] [Abstract][Full Text] [Related]
14. An overview of Food and Drug Administration regulation of drugs, biologics, and devices to be used for management of periodontal diseases.
Tylenda CA; Weintraub M
Ann Periodontol; 1997 Mar; 2(1):11-7. PubMed ID: 9151539
[TBL] [Abstract][Full Text] [Related]
15. Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017.
Dubin JR; Simon SD; Norrell K; Perera J; Gowen J; Cil A
JAMA Netw Open; 2021 May; 4(5):e217274. PubMed ID: 33956132
[TBL] [Abstract][Full Text] [Related]
16. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
[TBL] [Abstract][Full Text] [Related]
17. FDA regulation of cardiovascular devices and opportunities for improvement.
Dhruva SS; Redberg RF
J Interv Card Electrophysiol; 2013 Mar; 36(2):99-105. PubMed ID: 23263896
[TBL] [Abstract][Full Text] [Related]
18. ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products.
O'Neill T; Miksad R; Miller D; Maloney L; John A; Hiller C; Hornberger J
Value Health; 2019 Jul; 22(7):754-761. PubMed ID: 31277820
[TBL] [Abstract][Full Text] [Related]
19. FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979-2012.
Rome BN; Kramer DB; Kesselheim AS
JAMA; 2014 Jan 22-29; 311(4):385-91. PubMed ID: 24449317
[TBL] [Abstract][Full Text] [Related]
20. User fees and beyond--the FDA Safety and Innovation Act of 2012.
Kramer DB; Kesselheim AS
N Engl J Med; 2012 Oct; 367(14):1277-9. PubMed ID: 23034017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
